RT @DanaSpinant: The #EUPharmaStrategy also drives innovation for a more competitive industry:

• Stable rules keeping pace with innovation
• Faster authorization of innovative medicines
• Rewarding innovation
• Developing novel antimicrobials

2/3 https://t.co/OoPFg7acaH

🐦🔗: https://n.respublicae.eu/SKeersmaecker/status/1651239683219681281